{"id":"W4223609500","doi":"10.1016/j.eururo.2022.02.023","title":"Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Western University; Sunnybrook Health Science Centre","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Docetaxel; Enzalutamide; Prostate cancer; Prednisone; Internal medicine; Oncology; Pembrolizumab; Clinical endpoint; Cohort; Prostate-specific antigen; Cancer; Urology; Surgery; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003234485,0.0008251356,0.001149066,0.000284487,0.0004437218,0.0008630558,0.0006326194,0.0007269415,0.001823817],"category_scores_gemma":[0.001737461,0.0003936636,0.001284369,0.0005675282,0.0004903082,0.0008368811,0.0004028912,0.001818286,0.0004580956],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001088792,"about_ca_system_score_gemma":0.001594625,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003386866,"about_ca_topic_score_gemma":0.005280605,"domain_scores_codex":[0.999236,0.0003577162,0.00006018636,0.0001186751,0.0001166168,0.0001108621],"domain_scores_gemma":[0.9987161,0.0001456964,0.0004430171,0.0001183435,0.00008615046,0.0004906676],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8160958,0.02639919,0.0493368,0.0011493,0.003979332,0.00019912,0.0003170494,0.001413582,0.01034078,0.0002105575,0.005758715,0.08479981],"study_design_scores_gemma":[0.5234026,0.2857987,0.1745076,0.000241525,0.003506101,0.0004606195,0.0002132888,0.001201626,0.001896856,0.0002820907,0.008415856,0.00007308459],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990675,0.005422268,0.0002383928,0.0003763679,0.00007638569,0.0007064602,0.001536712,0.00002732057,0.0009409782],"genre_scores_gemma":[0.9912726,0.002551605,0.0005913214,0.0006979656,0.0002021525,0.0006098535,0.00318706,0.00001327147,0.0008740677],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003386866,"threshold_uncertainty_score":0.01710582,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02278533837395499,"score_gpt":0.3015875532335694,"score_spread":0.2788022148596145,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}